.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Somerset Indus Capital Partners recently announced the final close of its third fund, focusing on healthcare investment India. This fund reached approximately $288 million, which significantly exceeded the initial target of $250 million. Consequently, the firm aims to support affordable and accessible care in tier I and tier II cities. The capital will target sectors like pharmaceuticals, medical devices, and diagnostics. Furthermore, the participation from global and domestic investors underscores strong confidence in the Indian market.
Notably, the fund attracted interest from development finance institutions and family offices across Europe and the United States. Somerset typically invests between $15 million and $40 million per portfolio company. However, they can participate in larger transactions reaching $80 million through co-investment syndication. This strategy allows the firm to partner with entrepreneurs building scalable platforms. Therefore, these investments will likely drive innovation in preventive care and outpatient services.
The additional capital will specifically support opportunities in medical technology and OPD-linked insurance. Additionally, the firm plans to focus on diagnostics platforms that improve access beyond metro markets. Through Fund III, Somerset has already committed capital to three distinct businesses. These include Cyrix Healthcare, a medical equipment firm, and NU Hospitals, a Bengaluru-based hospital chain. Such diverse investments reflect a commitment to building a comprehensive healthcare ecosystem.
The firm has demonstrated a strong track record with its previous funds. For instance, Fund I returned four times the total capital to its investors. Similarly, Fund II is progressing toward successful exits, with its first realization also achieving a fourfold return. Consequently, these results validate Somerset's execution capabilities in the private equity space. The firm now manages around $500 million in total assets across its three flagship funds.
Q1: What is the primary focus of Somerset Indus Fund III?
The fund focuses on healthcare delivery, pharmaceuticals, medical devices, diagnostics, and allied segments across India's tier I and tier II cities.
Q2: Which companies has Fund III already invested in?
Somerset has already made investments in Kerala-based Cyrix Healthcare, pharmaceutical packaging firm Printmann Offset, and Bengaluru-based NU Hospitals.
Q3: How much does Somerset typically invest in a single company?
The firm usually invests between $15 million and $40 million, but can participate in deals up to $80 million via co-investment networks.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Somerset Indus Capital Partners has closed a $288 million healthcare fund to scale medical infrastructure and diagnostics across India's tier I and II citie...
4 months ago
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
